Eagle Pharmaceuticals
EGRX
#10440
Rank
S$5.76 M
Marketcap
S$0.45
Share price
0.00%
Change (1 day)
-59.32%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: S$5.76 Million

As of February 2026 Eagle Pharmaceuticals has a market cap of S$5.76 Million. This makes Eagle Pharmaceuticals the world's 10440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$5.76 M-22.94%
2025S$7.48 M-22.72%
2024S$9.68 M-89.2%
2023S$89.7 M-82.41%
2022S$0.51 B-42.63%
2021S$0.88 B10.74%
2020S$0.80 B-27.29%
2019S$1.10 B44.16%
2018S$0.76 B-28.17%
2017S$1.06 B-40.01%
2016S$1.77 B-9.39%
2015S$1.96 B582.2%
2014S$0.28 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
S$5.76 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$696.49 B 12,071,930.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$362.91 B 6,290,134.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$1.182 T 20,500,064.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$234.18 B 4,059,004.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$142.56 B 2,470,877.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$132.66 B 2,299,288.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$49.73 B 861,997.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel